United States · FDA National Drug Code directory
Midodrine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 60505-1325_37cdf8aa-c360-c39d-9b9c-a888ce26b6fb
- Product NDC
- 60505-1325
- Form
- TABLET
- Composition / generic term
- Midodrine Hydrochloride
- Labeler
- Apotex Corp
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20060912
- Source listing expiry
- 20271231
Source-listed ingredients
- MIDODRINE HYDROCHLORIDE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (60505-1325-1) · 60505-1325-1
- 30 TABLET in 1 BOTTLE (60505-1325-3) · 60505-1325-3
- 500 TABLET in 1 BOTTLE (60505-1325-5) · 60505-1325-5
- 1000 TABLET in 1 BOTTLE (60505-1325-8) · 60505-1325-8
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →